Details of the Drug

General Information of Drug (ID: DMI8NXY)

• Drug Name: MK-8189

Indication

Disease Entry	ICD 11	Status	REF
Schizophrenia	6A20	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 71271414
  TTD ID: D0YH5V

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)